Lista de obras -

COMPETITIVE TESTING THE WHO 2010 VS THE WHO 2017 GRADING OF PANCREAS NEUROENDOCRINE NEOPLASIA: DATA FROM A LARGE INTERNATIONAL COHORT STUDY

artículo científico publicado en 2018

Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework

artículo científico publicado en 2017

Effect of hormone secretory syndromes on neuroendocrine tumor prognosis

artículo científico publicado en 2017

Fewer cancer reoperations for medullary thyroid cancer after initial surgery according to ATA guidelines

artículo científico publicado en 2014

Hypertension en orthostatic hypotension during use of monoamine oxidase (MAO) inhibitors

artículo científico publicado en 2017

Importance of complete pathology reporting for neuroendocrine carcinoma: WHO guidelines are a good start but not enough

artículo científico publicado en 2020

Incidence and prognosis of carcinoid syndrome: hormones or tumour burden?

artículo científico publicado en 2017

Incidence and prognostic value of serotonin secretion in pancreatic neuroendocrine tumours

artículo científico publicado en 2017

Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours

artículo científico publicado en 2016

Management of carcinoid syndrome: a systematic review and meta-analysis

artículo científico publicado en 2019

Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours

artículo científico publicado en 2017

Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study

scientific article published on 01 February 2019

Role of biomarker tests for diagnosis of neuroendocrine tumours

scientific article published on 01 November 2018

Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors

artículo científico publicado en 2019

The Evolution of Neuroendocrine Tumor Treatment reflected by ENETS Guidelines

artículo científico publicado en 2018

Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE

scientific article published on 01 July 2019

Lista de obras de

COMPETITIVE TESTING THE WHO 2010 VS THE WHO 2017 GRADING OF PANCREAS NEUROENDOCRINE NEOPLASIA: DATA FROM A LARGE INTERNATIONAL COHORT STUDY

Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework

Effect of hormone secretory syndromes on neuroendocrine tumor prognosis

Fewer cancer reoperations for medullary thyroid cancer after initial surgery according to ATA guidelines

Hypertension en orthostatic hypotension during use of monoamine oxidase (MAO) inhibitors

Importance of complete pathology reporting for neuroendocrine carcinoma: WHO guidelines are a good start but not enough

Incidence and prognosis of carcinoid syndrome: hormones or tumour burden?

Incidence and prognostic value of serotonin secretion in pancreatic neuroendocrine tumours

Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours

Management of carcinoid syndrome: a systematic review and meta-analysis

Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours

Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study

Role of biomarker tests for diagnosis of neuroendocrine tumours

Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors

The Evolution of Neuroendocrine Tumor Treatment reflected by ENETS Guidelines

Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE